Page last updated: 2024-09-04

docetaxel anhydrous and Carcinosarcoma

docetaxel anhydrous has been researched along with Carcinosarcoma in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Ebata, T; Fujiwara, K; Fujiwara, Y; Hasegawa, K; Kato, T; Nishikawa, T; Noguchi, E; Shimomura, A; Sudo, K; Tamura, K; Yonemori, K	1
Conroy, M; Greally, M; MacEneaney, O; McCaffrey, J; O’Keane, C	1
Antoine, M; Bonnette, P; Cadranel, J; Cazes, A; Duruisseaux, M; Girard, N; Mazieres, J; Monnet, I; Ung, M; Vieira, T; Wislez, M	1
Bond, VK; Im, DD; Matsuo, K; Rosenshein, NB	1
Abulafia, O; Blessing, JA; Miller, BE; Richards, WE; Secord, AA; Shahin, MS; Stehman, FB; Van Le, L; Warshal, DP; Yamada, SD	1

Trials

1 trial(s) available for docetaxel anhydrous and Carcinosarcoma

Article	Year
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecologic oncology, 2010, Aug-01, Volume: 118, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Uterine Neoplasms	2010

Article

Year

A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.

Gynecologic oncology, 2010, Aug-01, Volume: 118, Issue:2

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Uterine Neoplasms

2010

Other Studies

4 other study(ies) available for docetaxel anhydrous and Carcinosarcoma

Article	Year
Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma. Oncology, 2020, Volume: 98, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Docetaxel; Doxorubicin; Female; Humans; Ifosfamide; Indazoles; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Progression-Free Survival; Pyrimidines; Retrospective Studies; Sulfonamides; Treatment Outcome; Uterine Neoplasms	2020
Sarcomatoid Carcinoma of the Prostate Presenting in a 44 Year Old Irish medical journal, 2018, 10-11, Volume: 111, Issue:9 Topics: Adult; Biopsy; Carcinosarcoma; Combined Modality Therapy; Docetaxel; Heart Neoplasms; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Palliative Care; Pleural Effusion, Malignant; Prostatic Neoplasms; Radiotherapy; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed	2018
Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Deoxycytidine; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gemcitabine; Giant Cell Tumors; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Quinazolines; Retrospective Studies; Sarcoma; Survival Rate; Taxoids; Vinblastine; Vinorelbine	2013
Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay. American journal of clinical oncology, 2010, Volume: 33, Issue:4 Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinosarcoma; Cisplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Taxoids; Uterine Neoplasms	2010